SCHEMBL247436

SCHEMBL247436

Cc1ccnc(-c2nc3cccc(F)c3c(Nc3cccc(N4CCOCC4)n3)c2C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 11/20 0.44
PIK3CD O00329 3/20 0.44
PIK3CB P42338 1/20 0.44
CDK1 P06493 1/20 0.40
CDK2 P24941 1/20 0.40
SMG1 Q96Q15 1/20 0.40
LRRK2 Q5S007 1/20 0.39
PIK3C2B O00750 1/20 0.39
MTOR P42345 1/20 0.39
PIK3CG P48736 1/20 0.39
CLK2 P49760 1/20 0.37
GSK3A P49840 1/20 0.37
GSK3B P49841 1/20 0.37
CSNK2A1 P68400 1/20 0.37
STK3 Q13188 1/20 0.37
HIPK4 Q8NE63 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37
KARS1 Q15046 2/20 0.37
PIK3R2 O00459 1/20 0.36
EPHB4 P54760 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL246138 0.91 PIK3CD (0.53) PIK3CAPIK3CDPIK3CBCDK1CDK2
SCHEMBL248279 0.83 PIK3CD (0.63) PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL27866839 0.82 PIK3CA (0.49) PIK3CAPIK3CDPIK3CBCDK1CDK2
SCHEMBL243776 0.80 PIK3CA (0.52) PIK3CAPIK3CD
SCHEMBL247135 0.80 PIK3CA (0.50) PIK3CAPIK3CDLRRK2PIK3R2
SCHEMBL248664 0.79 PIK3CA (0.41) PIK3CACDK1CDK2SMG1CLK2
SCHEMBL27866925 0.79 PIK3CA (0.48) PIK3CAPIK3CDPIK3CB
SCHEMBL248824 0.79 PIK3CD (0.45) PIK3CAPIK3CD
SCHEMBL246948 0.78 PIK3CD (0.49) PIK3CAPIK3CDSMG1LRRK2PIK3R2
SCHEMBL246551 0.77 HTT (0.39) PIK3CACDK1CDK2SMG1LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588471-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY Amgen Inc. (US) 2013-05-08 EP disclosed
WO-2012003283-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY AMGEN INC. (US) 2012-01-05 WO disclosed